Review



proteome profiler human cytokine array kit  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    R&D Systems proteome profiler human cytokine array kit
    Occludin modulates LPS-induced IL-8 secretion, barrier integrity, and cytoskeletal remodeling in human bronchial epithelial cells. (A) The BEAS-2b cells were transfected and were then incubated with LPS in a time-dependent manner before the generation of total cell lysates, and occludin transcripts were assessed by qRT-PCR. ∗ p < 0.05 compared to the control. (B) The cells were treated with LPS in a time-dependent manner. The occludin-specific antibody was assessed by Western blot analysis. β-actin was used as a loading control. (C) A construct expressing wild-type occludin or siRNA-occludin was transiently transfected into BEAS-2b cells. The cells were washed and serum-starved overnight. They were subsequently treated with LPS for 2 h and a <t>cytokine</t> assay was performed with cultured media and cell lysates were harvested for qRT-PCR of IL-8 (D) . The density of the resulting spots of IL-8 was measured using a densitometric analysis. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT occludin-treated transfectants. (E) The cells were transfected with either the wild-type occludin construct or siRNA-occuldin before incubation with LPS for various times, and then TEER testing was performed. Error bars represent the SEM of at least three independent experiments. (F) Cells were then treated with LPS for 2 h. F-actin staining was performed using ActinRed 555 ReadyProbe reagent (Molecular Probes) following the manufacturer's instructions. Cell nuclei were stained with diluted Deep Red (1:300). The fluorescence intensity was analyzed and statistically evaluated (right panel). ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT occludin-treated transfectants. All data are representative of at least three independent experiments.
    Proteome Profiler Human Cytokine Array Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 548 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cytokines/Proteome+Profiler+Human+Cytokine+Array+Kit/pmc12996814-57-0-9
    Average 96 stars, based on 548 article reviews
    proteome profiler human cytokine array kit - by Bioz Stars, 2026-09
    96/100 stars

    Images

    1) Product Images from "Prophylactic C-terminal occludin–derived peptide attenuates LPS-induced airway inflammation via barrier preservation and mitochondrial ROS regulation"

    Article Title: Prophylactic C-terminal occludin–derived peptide attenuates LPS-induced airway inflammation via barrier preservation and mitochondrial ROS regulation

    Journal: Redox Biology

    doi: 10.1016/j.redox.2026.104119

    Occludin modulates LPS-induced IL-8 secretion, barrier integrity, and cytoskeletal remodeling in human bronchial epithelial cells. (A) The BEAS-2b cells were transfected and were then incubated with LPS in a time-dependent manner before the generation of total cell lysates, and occludin transcripts were assessed by qRT-PCR. ∗ p < 0.05 compared to the control. (B) The cells were treated with LPS in a time-dependent manner. The occludin-specific antibody was assessed by Western blot analysis. β-actin was used as a loading control. (C) A construct expressing wild-type occludin or siRNA-occludin was transiently transfected into BEAS-2b cells. The cells were washed and serum-starved overnight. They were subsequently treated with LPS for 2 h and a cytokine assay was performed with cultured media and cell lysates were harvested for qRT-PCR of IL-8 (D) . The density of the resulting spots of IL-8 was measured using a densitometric analysis. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT occludin-treated transfectants. (E) The cells were transfected with either the wild-type occludin construct or siRNA-occuldin before incubation with LPS for various times, and then TEER testing was performed. Error bars represent the SEM of at least three independent experiments. (F) Cells were then treated with LPS for 2 h. F-actin staining was performed using ActinRed 555 ReadyProbe reagent (Molecular Probes) following the manufacturer's instructions. Cell nuclei were stained with diluted Deep Red (1:300). The fluorescence intensity was analyzed and statistically evaluated (right panel). ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT occludin-treated transfectants. All data are representative of at least three independent experiments.
    Figure Legend Snippet: Occludin modulates LPS-induced IL-8 secretion, barrier integrity, and cytoskeletal remodeling in human bronchial epithelial cells. (A) The BEAS-2b cells were transfected and were then incubated with LPS in a time-dependent manner before the generation of total cell lysates, and occludin transcripts were assessed by qRT-PCR. ∗ p < 0.05 compared to the control. (B) The cells were treated with LPS in a time-dependent manner. The occludin-specific antibody was assessed by Western blot analysis. β-actin was used as a loading control. (C) A construct expressing wild-type occludin or siRNA-occludin was transiently transfected into BEAS-2b cells. The cells were washed and serum-starved overnight. They were subsequently treated with LPS for 2 h and a cytokine assay was performed with cultured media and cell lysates were harvested for qRT-PCR of IL-8 (D) . The density of the resulting spots of IL-8 was measured using a densitometric analysis. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT occludin-treated transfectants. (E) The cells were transfected with either the wild-type occludin construct or siRNA-occuldin before incubation with LPS for various times, and then TEER testing was performed. Error bars represent the SEM of at least three independent experiments. (F) Cells were then treated with LPS for 2 h. F-actin staining was performed using ActinRed 555 ReadyProbe reagent (Molecular Probes) following the manufacturer's instructions. Cell nuclei were stained with diluted Deep Red (1:300). The fluorescence intensity was analyzed and statistically evaluated (right panel). ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT occludin-treated transfectants. All data are representative of at least three independent experiments.

    Techniques Used: Transfection, Incubation, Quantitative RT-PCR, Control, Western Blot, Construct, Expressing, Cytokine Assay, Cell Culture, Staining, Fluorescence

    The peptide regulates mitochondrial dysfunction and ROS production by inhibiting LPS-induced p38 activation. (A) The BEAS-2b cells were treated with wild-type occludin peptide (pepWT OCLN) or mutant occludin peptide (pepMut OCLN) and incubated with LPS for 15, 30 min. The phospho-specific and total antibodies were assessed by Western blot analysis. β-actin was used as a loading control. (B) The BEAS-2b cells were transfected with p38 overexpression construct (WT p38) or siRNA-p38 for 24 h and incubated with LPS for 4 h siRNA-scramble was used as a negative control. The proinflammatory cytokine transcripts were assessed by qRT-PCR. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT p38-transfected cells. (C) The mitochondrial membrane potential of LPS-induced BEAS-2b cells treated with either WT OCLN peptide or mut peptide was stained with JC-1 dye. Images are representative results of 3 independent experiments. (D) The mitochondria fission was stained using phospho-Drp1 antibody and visualized. The fluorescence intensity was analyzed and statistically evaluated (right panel). ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT OCLN peptide-treated transfectants. (E) After the BEAS-2b cells were harvested, cell lysates were used for MTT assay. (F) After mitochondria from the cells was isolated, the mitochondria lysates were used for mtROS measurement. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS only; ∗∗∗ p < 0.05 compared with LPS- and WT occludin peptide-treated cells. All data shown are representative of three independent experiments.
    Figure Legend Snippet: The peptide regulates mitochondrial dysfunction and ROS production by inhibiting LPS-induced p38 activation. (A) The BEAS-2b cells were treated with wild-type occludin peptide (pepWT OCLN) or mutant occludin peptide (pepMut OCLN) and incubated with LPS for 15, 30 min. The phospho-specific and total antibodies were assessed by Western blot analysis. β-actin was used as a loading control. (B) The BEAS-2b cells were transfected with p38 overexpression construct (WT p38) or siRNA-p38 for 24 h and incubated with LPS for 4 h siRNA-scramble was used as a negative control. The proinflammatory cytokine transcripts were assessed by qRT-PCR. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT p38-transfected cells. (C) The mitochondrial membrane potential of LPS-induced BEAS-2b cells treated with either WT OCLN peptide or mut peptide was stained with JC-1 dye. Images are representative results of 3 independent experiments. (D) The mitochondria fission was stained using phospho-Drp1 antibody and visualized. The fluorescence intensity was analyzed and statistically evaluated (right panel). ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT OCLN peptide-treated transfectants. (E) After the BEAS-2b cells were harvested, cell lysates were used for MTT assay. (F) After mitochondria from the cells was isolated, the mitochondria lysates were used for mtROS measurement. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS only; ∗∗∗ p < 0.05 compared with LPS- and WT occludin peptide-treated cells. All data shown are representative of three independent experiments.

    Techniques Used: Activation Assay, Mutagenesis, Incubation, Western Blot, Control, Transfection, Over Expression, Construct, Negative Control, Quantitative RT-PCR, Membrane, Staining, Fluorescence, MTT Assay, Isolation

    Related Articles

    Sterility:

    Article Title: Targeting IMPDH to inhibit SAMHD1 in KMT2A -rearranged leukaemia.
    Article Snippet: Blasts were then cultured at 1 × 106 cells/ml in StemPro-34 SFM supplemented with the StemPro Nutrient Supplement (10639011; Thermo Fisher Scientific) and the same additives used for cell line cultures. .. Media were further supplemented with sterile-filtered recombinant human cytokines at 20 ng/ml: IL-3 (R&D Systems, 203-IL-010), IL-6 (R&D Systems, 206-IL-025/ CF), GM-CSF (StemCell Technologies, 78,015.1), and TPO (StemCell Technologies, 78,210). ..

    Article Title: Targeting IMPDH to inhibit SAMHD1 in KMT2A -rearranged leukaemia
    Article Snippet: Blasts were then cultured at 1 × 10 6 cells/ml in StemPro-34 SFM supplemented with the StemPro Nutrient Supplement (10639011; Thermo Fisher Scientific) and the same additives used for cell line cultures. .. Media were further supplemented with sterile-filtered recombinant human cytokines at 20 ng/ml: IL-3 (R&D Systems, 203-IL-010), IL-6 (R&D Systems, 206-IL-025/CF), GM-CSF (StemCell Technologies, 78,015.1), and TPO (StemCell Technologies, 78,210). ..

    Recombinant:

    Article Title: Targeting IMPDH to inhibit SAMHD1 in KMT2A -rearranged leukaemia.
    Article Snippet: Blasts were then cultured at 1 × 106 cells/ml in StemPro-34 SFM supplemented with the StemPro Nutrient Supplement (10639011; Thermo Fisher Scientific) and the same additives used for cell line cultures. .. Media were further supplemented with sterile-filtered recombinant human cytokines at 20 ng/ml: IL-3 (R&D Systems, 203-IL-010), IL-6 (R&D Systems, 206-IL-025/ CF), GM-CSF (StemCell Technologies, 78,015.1), and TPO (StemCell Technologies, 78,210). ..

    Article Title: Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney disease.
    Article Snippet: Patients with chronic kidney disease (CKD) are at a significantly increased risk of stroke and experience worse stroke outcomes and higher mortality.. CKD exacerbates stroke risk and severity through a complex interplay of systemic inflammation, oxidative stress, and impaired clearance of uremic toxins, leading to neuroinflammation and microglial activation.. Current acute ischemic stroke treatments, while effective in the general population, do not adequately address CKD-specific mechanisms, limiting their efficacy in this high-risk population.

    Article Title: Targeting IMPDH to inhibit SAMHD1 in KMT2A -rearranged leukaemia
    Article Snippet: Blasts were then cultured at 1 × 10 6 cells/ml in StemPro-34 SFM supplemented with the StemPro Nutrient Supplement (10639011; Thermo Fisher Scientific) and the same additives used for cell line cultures. .. Media were further supplemented with sterile-filtered recombinant human cytokines at 20 ng/ml: IL-3 (R&D Systems, 203-IL-010), IL-6 (R&D Systems, 206-IL-025/CF), GM-CSF (StemCell Technologies, 78,015.1), and TPO (StemCell Technologies, 78,210). ..

    Article Title: Type I Interferon Signaling is Required for Oncostatin-M Driven Inflammatory Responses in Mouse Lung.
    Article Snippet: Type I interferons (IFNs) consist of a group of structurally similar cytokines that play an integral role in regulating the immune response to combat lung infections.. In certain models type I IFNs have also been associated with suppression of Th2-skewed immune and inflammatory responses.. Transient pulmonary overexpression of the gp130 cytokine Oncostatin M (OSM) by Adenovirus vector (AdOSM) induces a robust Th2-skewed cytokine/inflammatory profile in C57Bl/6 murine lungs.

    Article Title: A Transient Immunostimulatory Niche Synergizes Adoptive and Endogenous Immunity for Enhanced Tumor Control
    Article Snippet: .. Human cytokines were purchased from R&D Systems (Recombinant IL-2 Protein, Recombinant IL-7 Protein, Recombinant IL-2 Protein, Recombinant IL-15 Protein) and murine cytokines were purchased from Sino Biological (IL-2, IL-7, and IL-12A & IL-12B Heterodimer Protein (His Tag)) and PeproTech (Recombinant murine IL-15). ..

    Article Title: Interleukin-7 and interleukin-15 drive CD4 + CD28 null T lymphocyte expansion and function in patients with acute coronary syndrome
    Article Snippet: CD4 + T cells were cultured at 2×10 5 cells per well in U-bottom 96-well plates in RPMI1640 (Life Technologies) containing 100 U/mL penicillin, 100 μg/mL streptomycin, and 15 mM l -glutamine (Sigma-Aldrich), supplemented with 5% pooled human AB serum (Corning). .. Cells were stimulated with the indicated concentrations of recombinant human cytokines (IL-1β, IL-6, IL-7, IL-15, TNF-α; R&D Systems) and cultured for up to 11 days. .. Where indicated, cells were stimulated with IL-7/IL-15 in the presence or absence of 100 nM Tofacitinib (CP 690550 citrate, Tocris Bioscience).

    Article Title: Discoidin domain receptor 1 promotes Th17 cell migration by activating the RhoA/ROCK/MAPK/ERK signaling pathway
    Article Snippet: X-vivo 15 medium and the human T cell nucleofector kit were from Lonza technologies (Basel, PMA, ionomycin, collagenase IV, ROCK inhibitor (Y27632) and the general MMP inhibitor (GM6001) were from Sigma-Aldrich (St. Louis, MO). .. Human cytokines (TGF-β, IL-1β, IL-6, IL-23), the chemokine CCL20, the recombinant human and mouse blocking receptors DDR1:Fc and their respective isotypic controls, the recombinant human and mouse IgG-Fc fragments (control IgGs) were from R&D Systems (Minneapolis, MN). .. The human naïve CD4 + T cell isolation kit was from STEMCELL Technologies (Vancouver, BC).

    Article Title: Pathogenic Interleukin-10 Receptor Alpha Variants in Humans - Balancing Natural Selection and Clinical Implications.
    Article Snippet: PBMC were washed twice in PBS, and plated in 96-well flat bottom plates at the density of 5 × 105 cells/well in RPMI 1640 (Sigma) supplemented with 10% fetal bovine serum (Gibco), 1% penicillin, and streptomycin. .. Stimulations with recombinant human cytokines (IL10 (R&D Systems; Cat 217-IL-005), IL-6 (Peprotech; Cat 200–06), Universal type I interferon (pbl assay science; Cat 11,200–1)) were performed for 15 min after resting PBMC for 40 min. .. Following, cells were washed in Stain Buffer (BD Pharmingen; Cat 554,656) and stained using the APC-H7 Mouse Anti-Human CD3 (BD Pharmingen; Cat 560,176; Clone: SK7), FITC Mouse Anti-Human CD4 (BD Pharmingen; Cat 555,346; Clone: RPA-T4), and PE Mouse Anti-Human CD14 (BD Pharmingen; Cat 555,398; Clone: M5E2) for 15 min at 4 °C.

    Cell Culture:

    Article Title: Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney disease.
    Article Snippet: Patients with chronic kidney disease (CKD) are at a significantly increased risk of stroke and experience worse stroke outcomes and higher mortality.. CKD exacerbates stroke risk and severity through a complex interplay of systemic inflammation, oxidative stress, and impaired clearance of uremic toxins, leading to neuroinflammation and microglial activation.. Current acute ischemic stroke treatments, while effective in the general population, do not adequately address CKD-specific mechanisms, limiting their efficacy in this high-risk population.

    Article Title: Interleukin-7 and interleukin-15 drive CD4 + CD28 null T lymphocyte expansion and function in patients with acute coronary syndrome
    Article Snippet: CD4 + T cells were cultured at 2×10 5 cells per well in U-bottom 96-well plates in RPMI1640 (Life Technologies) containing 100 U/mL penicillin, 100 μg/mL streptomycin, and 15 mM l -glutamine (Sigma-Aldrich), supplemented with 5% pooled human AB serum (Corning). .. Cells were stimulated with the indicated concentrations of recombinant human cytokines (IL-1β, IL-6, IL-7, IL-15, TNF-α; R&D Systems) and cultured for up to 11 days. .. Where indicated, cells were stimulated with IL-7/IL-15 in the presence or absence of 100 nM Tofacitinib (CP 690550 citrate, Tocris Bioscience).

    Blocking Assay:

    Article Title: Discoidin domain receptor 1 promotes Th17 cell migration by activating the RhoA/ROCK/MAPK/ERK signaling pathway
    Article Snippet: X-vivo 15 medium and the human T cell nucleofector kit were from Lonza technologies (Basel, PMA, ionomycin, collagenase IV, ROCK inhibitor (Y27632) and the general MMP inhibitor (GM6001) were from Sigma-Aldrich (St. Louis, MO). .. Human cytokines (TGF-β, IL-1β, IL-6, IL-23), the chemokine CCL20, the recombinant human and mouse blocking receptors DDR1:Fc and their respective isotypic controls, the recombinant human and mouse IgG-Fc fragments (control IgGs) were from R&D Systems (Minneapolis, MN). .. The human naïve CD4 + T cell isolation kit was from STEMCELL Technologies (Vancouver, BC).

    Control:

    Article Title: Discoidin domain receptor 1 promotes Th17 cell migration by activating the RhoA/ROCK/MAPK/ERK signaling pathway
    Article Snippet: X-vivo 15 medium and the human T cell nucleofector kit were from Lonza technologies (Basel, PMA, ionomycin, collagenase IV, ROCK inhibitor (Y27632) and the general MMP inhibitor (GM6001) were from Sigma-Aldrich (St. Louis, MO). .. Human cytokines (TGF-β, IL-1β, IL-6, IL-23), the chemokine CCL20, the recombinant human and mouse blocking receptors DDR1:Fc and their respective isotypic controls, the recombinant human and mouse IgG-Fc fragments (control IgGs) were from R&D Systems (Minneapolis, MN). .. The human naïve CD4 + T cell isolation kit was from STEMCELL Technologies (Vancouver, BC).



    Similar Products

    97
    Miltenyi Biotec macsplex cytokine 12 kit
    Macsplex Cytokine 12 Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cytokines/MACSPlex+Cytokine+12+Kit%2C+human/us12678462-343-23-28
    Average 97 stars, based on 1 article reviews
    macsplex cytokine 12 kit - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Bio-Techne corporation proteome profiler human cytokine array kit
    Proteome Profiler Human Cytokine Array Kit, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cytokines/Proteome+Profiler+Human+Cytokine+Array+Kit/bio-techne+corporation___ary005b
    Average 97 stars, based on 1 article reviews
    proteome profiler human cytokine array kit - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    96
    Akoya Biosciences kits opal 6 plex manual detection kit akoya biosciences nel811001kt bio plex pro human cytokine 27 plex assay bio rad
    Kits Opal 6 Plex Manual Detection Kit Akoya Biosciences Nel811001kt Bio Plex Pro Human Cytokine 27 Plex Assay Bio Rad, supplied by Akoya Biosciences, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cytokines/Opal+6-Plex+Detection+Kit/pm42230989-250-28-34
    Average 96 stars, based on 1 article reviews
    kits opal 6 plex manual detection kit akoya biosciences nel811001kt bio plex pro human cytokine 27 plex assay bio rad - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec human macsplex cytokine 12 kit
    Human Macsplex Cytokine 12 Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cytokines/MACSPlex+Cytokine+12+Kit%2C+human/bio_rxiv__64898__2026__07__03__736407-67-27-32
    Average 97 stars, based on 1 article reviews
    human macsplex cytokine 12 kit - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    98
    Thermo Fisher cytokines tumor necrosis factor α tnf α
    Cytokines Tumor Necrosis Factor α Tnf α, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cytokines/Tumor+Necrosis+Factor-alpha%2C+human/pm42114754-91-38-63
    Average 98 stars, based on 1 article reviews
    cytokines tumor necrosis factor α tnf α - by Bioz Stars, 2026-09
    98/100 stars
      Buy from Supplier

    86
    Eve Technologies Corporation human cytokine chemokine 96 plex discovery assay array hd96 panel
    Hyperoxia‐induced senescent fASM secrete higher levels of SASP. Cells cultured till day 7 in normoxic (21% O 2 ) or hyperoxic (50% O 2 ) environment were incubated with fresh growth media in normoxia for 24 h, and the supernatants were collected. Samples were then analyzed for SASP secretion by Eve Technologies Corporation (Calgary, Alberta, Canada) using Luminex xMAP and the Human <t>Cytokine/Chemokine</t> <t>96‐Plex</t> Discovery Assay Array <t>(HD96)</t> panel. (A) Out of the 96 proteins, 80 were detected and visualized using a heatmap. (B) A detailed analysis of each detected marker is shown as fold‐change normalized to control. For statistical analysis, 2‐way ANOVA with a two‐stage linear step‐up procedure of Benjamini, Krieger and Yekutieli test, with individual variances computed for each comparison was applied. False discovery rate < 0.05 was considered significant. Data are presented as box plot of n = 7 cell lines per group.
    Human Cytokine Chemokine 96 Plex Discovery Assay Array Hd96 Panel, supplied by Eve Technologies Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cytokines/31+array+array+chemokine+cytokine+mouse+plex/pmc13154765-167-24-16
    Average 86 stars, based on 1 article reviews
    human cytokine chemokine 96 plex discovery assay array hd96 panel - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Eve Technologies Corporation human cytokine chemokine 71 plex discovery assay array
    Hyperoxia‐induced senescent fASM secrete higher levels of SASP. Cells cultured till day 7 in normoxic (21% O 2 ) or hyperoxic (50% O 2 ) environment were incubated with fresh growth media in normoxia for 24 h, and the supernatants were collected. Samples were then analyzed for SASP secretion by Eve Technologies Corporation (Calgary, Alberta, Canada) using Luminex xMAP and the Human <t>Cytokine/Chemokine</t> <t>96‐Plex</t> Discovery Assay Array <t>(HD96)</t> panel. (A) Out of the 96 proteins, 80 were detected and visualized using a heatmap. (B) A detailed analysis of each detected marker is shown as fold‐change normalized to control. For statistical analysis, 2‐way ANOVA with a two‐stage linear step‐up procedure of Benjamini, Krieger and Yekutieli test, with individual variances computed for each comparison was applied. False discovery rate < 0.05 was considered significant. Data are presented as box plot of n = 7 cell lines per group.
    Human Cytokine Chemokine 71 Plex Discovery Assay Array, supplied by Eve Technologies Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cytokines/31+array+array+chemokine+cytokine+mouse+plex/bio_rxiv__64898__2026__05__01__722277-62-26-17
    Average 86 stars, based on 1 article reviews
    human cytokine chemokine 71 plex discovery assay array - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    96
    R&D Systems proteome profiler human cytokine array kit
    Occludin modulates LPS-induced IL-8 secretion, barrier integrity, and cytoskeletal remodeling in human bronchial epithelial cells. (A) The BEAS-2b cells were transfected and were then incubated with LPS in a time-dependent manner before the generation of total cell lysates, and occludin transcripts were assessed by qRT-PCR. ∗ p < 0.05 compared to the control. (B) The cells were treated with LPS in a time-dependent manner. The occludin-specific antibody was assessed by Western blot analysis. β-actin was used as a loading control. (C) A construct expressing wild-type occludin or siRNA-occludin was transiently transfected into BEAS-2b cells. The cells were washed and serum-starved overnight. They were subsequently treated with LPS for 2 h and a <t>cytokine</t> assay was performed with cultured media and cell lysates were harvested for qRT-PCR of IL-8 (D) . The density of the resulting spots of IL-8 was measured using a densitometric analysis. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT occludin-treated transfectants. (E) The cells were transfected with either the wild-type occludin construct or siRNA-occuldin before incubation with LPS for various times, and then TEER testing was performed. Error bars represent the SEM of at least three independent experiments. (F) Cells were then treated with LPS for 2 h. F-actin staining was performed using ActinRed 555 ReadyProbe reagent (Molecular Probes) following the manufacturer's instructions. Cell nuclei were stained with diluted Deep Red (1:300). The fluorescence intensity was analyzed and statistically evaluated (right panel). ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT occludin-treated transfectants. All data are representative of at least three independent experiments.
    Proteome Profiler Human Cytokine Array Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cytokines/Proteome+Profiler+Human+Cytokine+Array+Kit/pmc12996814-57-0-9
    Average 96 stars, based on 1 article reviews
    proteome profiler human cytokine array kit - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    Image Search Results


    Hyperoxia‐induced senescent fASM secrete higher levels of SASP. Cells cultured till day 7 in normoxic (21% O 2 ) or hyperoxic (50% O 2 ) environment were incubated with fresh growth media in normoxia for 24 h, and the supernatants were collected. Samples were then analyzed for SASP secretion by Eve Technologies Corporation (Calgary, Alberta, Canada) using Luminex xMAP and the Human Cytokine/Chemokine 96‐Plex Discovery Assay Array (HD96) panel. (A) Out of the 96 proteins, 80 were detected and visualized using a heatmap. (B) A detailed analysis of each detected marker is shown as fold‐change normalized to control. For statistical analysis, 2‐way ANOVA with a two‐stage linear step‐up procedure of Benjamini, Krieger and Yekutieli test, with individual variances computed for each comparison was applied. False discovery rate < 0.05 was considered significant. Data are presented as box plot of n = 7 cell lines per group.

    Journal: Aging Cell

    Article Title: Targeting Hyperoxia‐Induced Cellular Senescence in Developing Human Airway Cells: Senomorphics Versus Senolytics Versus Antioxidants

    doi: 10.1111/acel.70538

    Figure Lengend Snippet: Hyperoxia‐induced senescent fASM secrete higher levels of SASP. Cells cultured till day 7 in normoxic (21% O 2 ) or hyperoxic (50% O 2 ) environment were incubated with fresh growth media in normoxia for 24 h, and the supernatants were collected. Samples were then analyzed for SASP secretion by Eve Technologies Corporation (Calgary, Alberta, Canada) using Luminex xMAP and the Human Cytokine/Chemokine 96‐Plex Discovery Assay Array (HD96) panel. (A) Out of the 96 proteins, 80 were detected and visualized using a heatmap. (B) A detailed analysis of each detected marker is shown as fold‐change normalized to control. For statistical analysis, 2‐way ANOVA with a two‐stage linear step‐up procedure of Benjamini, Krieger and Yekutieli test, with individual variances computed for each comparison was applied. False discovery rate < 0.05 was considered significant. Data are presented as box plot of n = 7 cell lines per group.

    Article Snippet: Supernatants collected at day 8 from normoxia and hyperoxia‐exposed fASM were analyzed for SASP secretion by Eve Technologies Corporation (Calgary, Alberta, Canada) using the Human Cytokine/Chemokine 96‐Plex Discovery Assay Array (HD96) panel.

    Techniques: Cell Culture, Incubation, Luminex, Marker, Control, Comparison

    Occludin modulates LPS-induced IL-8 secretion, barrier integrity, and cytoskeletal remodeling in human bronchial epithelial cells. (A) The BEAS-2b cells were transfected and were then incubated with LPS in a time-dependent manner before the generation of total cell lysates, and occludin transcripts were assessed by qRT-PCR. ∗ p < 0.05 compared to the control. (B) The cells were treated with LPS in a time-dependent manner. The occludin-specific antibody was assessed by Western blot analysis. β-actin was used as a loading control. (C) A construct expressing wild-type occludin or siRNA-occludin was transiently transfected into BEAS-2b cells. The cells were washed and serum-starved overnight. They were subsequently treated with LPS for 2 h and a cytokine assay was performed with cultured media and cell lysates were harvested for qRT-PCR of IL-8 (D) . The density of the resulting spots of IL-8 was measured using a densitometric analysis. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT occludin-treated transfectants. (E) The cells were transfected with either the wild-type occludin construct or siRNA-occuldin before incubation with LPS for various times, and then TEER testing was performed. Error bars represent the SEM of at least three independent experiments. (F) Cells were then treated with LPS for 2 h. F-actin staining was performed using ActinRed 555 ReadyProbe reagent (Molecular Probes) following the manufacturer's instructions. Cell nuclei were stained with diluted Deep Red (1:300). The fluorescence intensity was analyzed and statistically evaluated (right panel). ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT occludin-treated transfectants. All data are representative of at least three independent experiments.

    Journal: Redox Biology

    Article Title: Prophylactic C-terminal occludin–derived peptide attenuates LPS-induced airway inflammation via barrier preservation and mitochondrial ROS regulation

    doi: 10.1016/j.redox.2026.104119

    Figure Lengend Snippet: Occludin modulates LPS-induced IL-8 secretion, barrier integrity, and cytoskeletal remodeling in human bronchial epithelial cells. (A) The BEAS-2b cells were transfected and were then incubated with LPS in a time-dependent manner before the generation of total cell lysates, and occludin transcripts were assessed by qRT-PCR. ∗ p < 0.05 compared to the control. (B) The cells were treated with LPS in a time-dependent manner. The occludin-specific antibody was assessed by Western blot analysis. β-actin was used as a loading control. (C) A construct expressing wild-type occludin or siRNA-occludin was transiently transfected into BEAS-2b cells. The cells were washed and serum-starved overnight. They were subsequently treated with LPS for 2 h and a cytokine assay was performed with cultured media and cell lysates were harvested for qRT-PCR of IL-8 (D) . The density of the resulting spots of IL-8 was measured using a densitometric analysis. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT occludin-treated transfectants. (E) The cells were transfected with either the wild-type occludin construct or siRNA-occuldin before incubation with LPS for various times, and then TEER testing was performed. Error bars represent the SEM of at least three independent experiments. (F) Cells were then treated with LPS for 2 h. F-actin staining was performed using ActinRed 555 ReadyProbe reagent (Molecular Probes) following the manufacturer's instructions. Cell nuclei were stained with diluted Deep Red (1:300). The fluorescence intensity was analyzed and statistically evaluated (right panel). ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT occludin-treated transfectants. All data are representative of at least three independent experiments.

    Article Snippet: Proteome Profiler Human Cytokine Array kit was purchased from R&D Systems (cat no. ARY005B, USA).

    Techniques: Transfection, Incubation, Quantitative RT-PCR, Control, Western Blot, Construct, Expressing, Cytokine Assay, Cell Culture, Staining, Fluorescence

    The peptide regulates mitochondrial dysfunction and ROS production by inhibiting LPS-induced p38 activation. (A) The BEAS-2b cells were treated with wild-type occludin peptide (pepWT OCLN) or mutant occludin peptide (pepMut OCLN) and incubated with LPS for 15, 30 min. The phospho-specific and total antibodies were assessed by Western blot analysis. β-actin was used as a loading control. (B) The BEAS-2b cells were transfected with p38 overexpression construct (WT p38) or siRNA-p38 for 24 h and incubated with LPS for 4 h siRNA-scramble was used as a negative control. The proinflammatory cytokine transcripts were assessed by qRT-PCR. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT p38-transfected cells. (C) The mitochondrial membrane potential of LPS-induced BEAS-2b cells treated with either WT OCLN peptide or mut peptide was stained with JC-1 dye. Images are representative results of 3 independent experiments. (D) The mitochondria fission was stained using phospho-Drp1 antibody and visualized. The fluorescence intensity was analyzed and statistically evaluated (right panel). ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT OCLN peptide-treated transfectants. (E) After the BEAS-2b cells were harvested, cell lysates were used for MTT assay. (F) After mitochondria from the cells was isolated, the mitochondria lysates were used for mtROS measurement. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS only; ∗∗∗ p < 0.05 compared with LPS- and WT occludin peptide-treated cells. All data shown are representative of three independent experiments.

    Journal: Redox Biology

    Article Title: Prophylactic C-terminal occludin–derived peptide attenuates LPS-induced airway inflammation via barrier preservation and mitochondrial ROS regulation

    doi: 10.1016/j.redox.2026.104119

    Figure Lengend Snippet: The peptide regulates mitochondrial dysfunction and ROS production by inhibiting LPS-induced p38 activation. (A) The BEAS-2b cells were treated with wild-type occludin peptide (pepWT OCLN) or mutant occludin peptide (pepMut OCLN) and incubated with LPS for 15, 30 min. The phospho-specific and total antibodies were assessed by Western blot analysis. β-actin was used as a loading control. (B) The BEAS-2b cells were transfected with p38 overexpression construct (WT p38) or siRNA-p38 for 24 h and incubated with LPS for 4 h siRNA-scramble was used as a negative control. The proinflammatory cytokine transcripts were assessed by qRT-PCR. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT p38-transfected cells. (C) The mitochondrial membrane potential of LPS-induced BEAS-2b cells treated with either WT OCLN peptide or mut peptide was stained with JC-1 dye. Images are representative results of 3 independent experiments. (D) The mitochondria fission was stained using phospho-Drp1 antibody and visualized. The fluorescence intensity was analyzed and statistically evaluated (right panel). ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS treatment; ∗∗∗ p < 0.05 compared with WT OCLN peptide-treated transfectants. (E) After the BEAS-2b cells were harvested, cell lysates were used for MTT assay. (F) After mitochondria from the cells was isolated, the mitochondria lysates were used for mtROS measurement. ∗ p < 0.05 compared with control; ∗∗ p < 0.05 compared with LPS only; ∗∗∗ p < 0.05 compared with LPS- and WT occludin peptide-treated cells. All data shown are representative of three independent experiments.

    Article Snippet: Proteome Profiler Human Cytokine Array kit was purchased from R&D Systems (cat no. ARY005B, USA).

    Techniques: Activation Assay, Mutagenesis, Incubation, Western Blot, Control, Transfection, Over Expression, Construct, Negative Control, Quantitative RT-PCR, Membrane, Staining, Fluorescence, MTT Assay, Isolation